TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.

Napaporn Chantasrisawad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.